On ECHEMI
Home > Drugs > Eclampsia
Eclampsia
Eclampsia is a special manifestation of "pregnancy-induced hypertension syndrome" (abbreviated as PIH) after 20 weeks of pregnancy, including edema, hypertension and proteinuria. It is especially serious and urgent in the late pregnancy, characterized by convulsions and coma, and may be complicated by renal failure, heart failure, pulmonary edema, intracranial hemorrhage, early placental abruption, etc. Preeclampsia is a stage before convulsions, accompanied by headache, dizziness, blurred vision, upper abdominal discomfort, nausea and other symptoms on the basis of PIH, indicating that eclampsia is about to occur.
Related Drugs
Antelope Horn Capsules
Manufacturer:

Zhejiang YIXIN Pharmaceutical Co., Ltd.

MAGNESIUM SULFATE- magnesium sulfate heptahydrate_injection, solution
Indication: Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.
Manufacturer:

Baxter Healthcare Corporation

MAGNESIUM SULFATE- magnesium sulfate heptahydrate_injection, solution
Indication: Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.
Manufacturer:

Baxter Healthcare Corporation

PHENOBARBITAL SODIUM- phenobarbital sodium_injection
Indication: INDICATIONS AND USAGE Parenteral
Sedative. Sedation is obtainable within an hour, and in adequate dosage, the duration of action is more than six hours. Included in the more common conditions in which the sedative action of this class of drugs is desired are anxiety-tension states, hyperthyroidism, essential hypertension, nausea and vomiting of functional origin, motion sickness, acute labyrinthitis, pylorospasm in infants, chorea and cardiac failure. Phenobarbital is also a useful adjunct in treatment of hemorrhage from the respiratory or gastrointestinal tract. Phenobarbital controls anxiety, decreases muscular activity and lessens nervous excitability in hyperthyroid patients. However, thyrotoxic individuals occasionally react poorly to barbiturates. Hypnotic, for the short-term treatment of insomnia, since it appears to lose its effectiveness for sleep induction and sleep maintenance after 2 weeks (see CLINICAL PHARMACOLOGY Preanesthetic. Long-term anticonvulsant, (phenobarbital, mephobarbital and metharbital) for the treatment of generalized tonic-clonic and cortical focal seizures. And, in the emergency control of certain acute convulsive episodes, e.g., those associated with status epilepticus, cholera, eclampsia, cerebral hemorrhage, meningitis, tetanus, and toxic reactions to strychnine or local anesthetics. Phenobarbital sodium may be administered intramuscularly or intravenously as an anticonvulsant for emergency use. When administered intravenously, it may require 15 or more minutes before reaching peak concentrations in the brain. Therefore, injecting phenobarbital sodium until the convulsions stop may cause the brain level to exceed that required to control the convulsions and lead to severe barbiturate-induced depression. Phenobarbital is indicated in pediatric patients as an anticonvulsant and as a sedative, including its preoperative and postoperative use.
Nervous System
Somnolence, agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, hallucinations, insomnia, anxiety, dizziness, thinking abnormality
Manufacturer:

Bryant Ranch Prepack

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.